Stephan C. Bischoff, Johanna Escher, Xavier Hébuterne, Stanisław Kłęk, Zeljko Krznaric, Stéphane Schneider, Raanan Shamir, Kalina Stardelova, Nicolette Wierdsma, Anthony E. Wiskin, Alastair Forbes

 Clinical Nutrition 39 (2020) 632-653

A.A. KAMALOVA, E.R. SAFINA, G.A. GARINA, A.R. GAYFUTDINOVA

Kazan State Medical University, Kazan

Contact details:

Kamalova A.A. — MD, Professor of the Department of Hospital Pediatrics

Address: 49 Butlerov St., Kazan, Russian Federation, 420012, tel.: +7 (843) 237-30-37, e-mail: aelitakamalova@gmail.com

The article presents an adapted translation of the current ESPEN (European Society for Clinical Nutrition and Metabolism) practical guideline: Clinical Nutrition in inflammatory bowel disease (2020).

Key words: Crohn’s disease, ulcerative colitis, enteral nutrition, parenteral nutrition, inflammatory bowel disease, diet therapy.

 (For citation: Kamalova A.A., Safina E.R., Garina G.A., Gayfutdinova A.R. ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease. Practical medicine. 2021. Vol. , № , P.)

 REFERENCES

1. Bischoff S.C., Escher J., Hébuterne X., Kłęk S., Krznaric Z., Schneider S. et al. ESPEN practical guideline: Clinical nutrition in inflammatory bowel disease. ClinNutr, 2020, vol. 39, pp. 632–653
2. Forbes A., Escher J., Hébuterne X., Kłęk S., Krznaric Z., Schneider S. et al. ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clin Nutr, 2017, vol. 36, pp. 321–347.
3. Bischoff S.C., Singer P., Koller M., Barazzoni R., Cederholm T., van Gossum A. Standard operating pro-cedures for ESPEN guidelines and consensus papers. Clin Nutr, 2015, vol. 34, pp. 1043–1051.
4. Hou J.K., Abraham B., El-Serag H. Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature. Am J Gastroenterol, 2011, vol. 106, pp. 563–573.
5. Ananthakrishnan A.N., Khalili H., Konijeti G.G., Higuchi L.M., de Silva P., Fuchs C.S. et al. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn’s disease. Gut, 2014, vol. 63, pp. 776–784.
6. Klement E., Cohen R.V., Boxman J., Joseph A., Reif S. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr, 2004, vol. 80, pp. 1342–1352.
7. Barclay A.R., Russell R.K., Wilson M.L., Gilmour W.H., Satsangi J., Wilson D.C. Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease. J Pediatr, 2009, vol. 155, pp. 421–426.
8. Nguyen G.C., Munsell M., Harris M.L. Nationwide prevalence and prognostic significance of clinically diagnosa-ble protein-calorie malnutrition in hospitalized inflammatory bowel disease patients. Inflamm Bowel Dis, 2008, vol. 14, pp. 1105–1111.
9. Sandhu A., Mosli M., Yan B., Wu T., Gregor J., Chande N. et al. Self-Screening for Malnutrition Risk in Outpatient Inflammatory Bowel Disease Patients Using the Malnutrition Universal Screening Tool (MUST). JPEN J Parenter Enteral Nutr, 2016, vol. 40, pp. 507–510.
10. Vasseur F., Gower-Rousseau C., Vernier-Massouille G., Dupas J.L., Merle V., Merlin B. et al. Nutritional Status and Growth in Pediatric Crohn’s Disease: A Population-Based Study. Am J Gastroenterol, 2010, vol. 105, pp. 1893–1900.
11. Hill R.J., Davies P.S. You look all right to me: compromised nutritional status in paediatric patients with ulcerative colitis. J Pediatr Gastroenterol Nutr, 2013, vol. 56, pp. 385–389.
12. Gerasimidis K., Edwards C., Stefanowicz F., Galloway P., McGrogan P., Duncan A. et al. Micronutrient status in children with IBD: true deficiencies or epiphenomenon of the systemic inflammatory response. J Pediatr Gastroenterol Nutr, 2013, vol. 56, pp. e50–51.
13. Vagianos K., Bector S., McConnell J., Bernstein C.N. Nutrition assessment of patients with inflammatory bowel disease. JPEN. Jour Jarenter Enteral Nutr, 2007, vol. 31, pp. 311–319.
14. Dignass A.U., Gasche C., Bettenworth D., Birgegård G., Danese S., Gisbert J.P. et al. European Crohn’s and Colitis Organisation [ECCO]. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis, 2015, vol. 9, pp. 211–222.
15. Dignass A.U., Gasche C., Bettenworth D., Birgegård G., Danese S., Gisbert J.P. et al. European Crohn’s and Colitis Organisation [ECCO]. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis, 2015, vol. 9, pp. 211–222.
16. Evstatiev R., Marteau P., Iqbal T., Khalif I.L., Stein J., Bokemeyer B. et al. FERGIcor, a randomized con-trolled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroen-terology, 2011, vol. 141, pp. 846–853, e1–2.
17. Pironi L., Arends J., Baxter J., Bozzetti F., Peláez R.B., Cuerda C. et al. Home Artificial Nutrition & Chronic Intestinal Failure; Acute Intestinal Failure Special Interest Groups of ESPEN. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr, 2015, vol. 34, pp. 171–180.
18. Lopes L.H., Sdepanian V.L., Szejnfeld V.L., de Morais M.B., Fagundes-Neto U. Risk factors for low bone mineral density in children and adolescents with inflammatory bowel disease. Dig Dis Sci, 2008, vol. 53, pp. 2746–2753.
19. Hebuterne X., Filippi J., Al-Jaouni R., Schneider S. Nutritional consequences and nutrition therapy in Crohn’s disease. Gastroenterol Clin Biol, 2009, vol. 33 (3), pp. S235–244.
20. Jacobsen O., Højgaard L., Hylander Møller E., Wielandt T.O., Thale M. et al. Effect of enterocoated cholestyramine on bowel habit after ileal resection: a double blind crossover study. Br Med J (Clin Res Ed), 1985, vol. 290, pp. 1315–1318.
21. Little K.H., Schiller L.R., Bilhartz L.E., Fordtran J.S. Treatment of severe steatorrhea with ox bile in an ileectomy patient with residual colon. Dig Dis Sci, 1992, vol. 37, pp. 929–933.
22. Andersson H., Filipsson S., Hultén L. Urinary oxalate excretion related to ileocolic surgery in patients with Crohn’s disease. Scand J Gastroenterol, 1978, vol. 13, pp. 465–469.
23. Charlebois A., Rosenfeld G., Bressler B. The Impact of Dietary Interventions on the Symptoms of Inflammatory Bowel Disease: A Systematic Review. Crit Rev Food Sci Nutr., 2016, vol. 56, pp. 1370–1378.
24. Sigall-Boneh R., Pfeffer-Gik T., Segal I., Zangen T., Boaz M., Levine A. Partial enteral nutrition with a Crohn’s disease exclusion diet is effective for induction of remission in children and young adults with Crohn’s disease. Inflamm Bowel Dis, 2014, vol. 20, pp. 1353–1360.
25. Rajendran N., Kumar D. Food-specific IgG4-guided exclusion diets improve symptoms in Crohn’s disease: a pilot study. Colorectal Dis, 2011, vol. 13, pp. 1009–1013.
26. Carter M.J., Lobo A.J., Travis S.P. Guidelines for the management of inflammatory bowel disease in adults. Gut, 2004, vol. 53 (5), pp. V1–16.
27. Valentini L., Schaper L., Buning C., Hengstermann S., Koernicke T., Tillinger W. et al. Malnutrition and impaired muscle strength in patients with Crohn’s disease and ulcerative colitis in remission. Nutrition, 2008, vol. 24, pp. 694–702.
28. Smith M.A., Smith T., Trebble T. Nutritional management of adults with inflammatory bowel disease: practical lessons from the available evidence. Frontline Gastroenterology, 2012, vol. 3, pp. 172–179.
29. Li G., Ren J., Wang G., Hu D., Gu G., Liu S. et al. Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn’s disease. Eur J Clin Nutr, 2014, vol. 68, pp. 441–446.
30. Yan D., Ren J., Wang G., Liu S., Li J. Predictors of response to enteral nutrition in abdominal enterocutaneous fistula patients with Crohn’s disease. Eur J Clin Nutr, 2014, vol. 68, pp. 959–963.
31. Visschers R.G., Olde Damink S.W., Winkens B., Soeters P., van Gemert W.G. Treatment strategies in 135 consecutive patients with enterocutaneous fistulas. World J Surg, 2008, vol. 32, pp. 445–453.
32. Llop J.M., Cobo S., Padulles A., Farran L., Jodar R., Badia M.B. Nutritional support and risk factors of appearance of enterocutaneous fistulas. Nutr Hosp, 2012, vol. 27, pp. 213–218.
33. Visschers R.G., Olde Damink S.W., Winkens B., Soeters P., van Gemert W.G. Treatment strategies in 135 consecutive patients with enterocutaneous fistulas. World J Surg, 2008, vol. 32, pp. 445–453.
34. Dignass A., Lindsay J.O., Sturm A., Windsor A., Colombel J.F., Allez M. et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management. J Crohn Colitis, 2012, vol. 6, pp. 991–1030.
35. Weimann A., Braga M., Carli F., Higashiguchi T., Hübner M., Klek S. et al. ESPEN guideline: Clinical nutrition in surgery. Clin Nutr, 2017, vol. 6, pp. 623–650.
36. Lev-Tzion R., Griffiths A.M., Leder O., Turner D. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev, 2014, vol. 2. CD006320.
37. Fujiya M., Ueno N., Kohgo Y. Probiotic treatments for induction and maintenance of remission in inflammatory bowel diseases: a meta-analysis of randomized controlled trials. Clin J Gastroenterol, 2014, vol. 7, pp. 1–13.
38. El-Matary W., Otley A., Critch J., Abou-Setta A.M. Enteral Feeding Therapy for Maintaining Remission in Crohn’s Disease: A Systematic Review. JPEN J Parenter Enteral Nutr, 2015, vol. 41, pp. 550–561.
39. Ruemmele F.M., Veres G., Kolho K.L., Griffiths A., Levine A., Escher J.C. et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. J Crohns Colitis, 2014, vol. 8, pp. 1179–1207.
40. Stabler S.P. Clinical practice. Vitamin B12 deficiency. N Engl J Med, 2013, vol. 368, pp. 149–160.